PRI Institute
Advancing scientific research to transform the understanding and treatment of PTEN-related disorders and cancer susceptibility syndromes.
Faculty & Research
A team of leading scientists and clinicians dedicated to pioneering discoveries in PTEN biology and innovative therapeutic approaches.
News & Events
Stay updated on the latest breakthroughs, publications, and key events shaping the future of PTEN research and cancer treatment.
Our Mission
Our Institute aims at developing effective therapeutic interventions to alleviate the manifestations of PTEN Hamartomas Tumor Syndromes (PHTS) and other Cancer Susceptibility Syndromes, but also to implement treatment modalities to prevent and cure cancer at large
Goals
To foster research and collaboration on PTEN and its pathways, on cancer susceptibility and cancer prevention at large.
To propose and implement clinical trials in PHTS, in Cancer Susceptibility Syndromes, and in somatic cancers where relevant players and pathways are altered, with the goal of preventing and curing cancer.
To fund selected projects and clinical trials.